Patent · US Active

Crystalline anti-human IL-12 antibodies

US8404819B2 · kind B2 · utility

2Cited by

38References

49Claims

0Family size

Assignee

Abb Vie Inc. · US

Inventors

David W. Borhani · Worcester, US
Wolfgang Fraunhofer · Gurnee, US
Hans-Juergen Krause · Havelsee, DE
Anette Koenigsdorfer · Ilvesheim, DE
Gerhard Winter · Dossenheim, DE
Stefan Gottschalk · Grünwald, DE

Key dates

Filing date	Feb 14, 2012
Grant date	Mar 26, 2013
Priority date	—
Expiry date	Feb 14, 2032

Classification

Technology area (CPC Y)Emerging Cross-Sectional Technologies
CPC primaryY02A50/30
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The invention relates to batch crystallization methods for crystallizing an anti-hIL-12 antibody that allows the production of the antibody on an industrial scale, antibody crystals obtained according to the methods, compositions containing the crystals, and methods of using the crystals and the compositions.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.